David Kyle

Board Member and Strategic Advisor, Evolve Biosystems
When
3rd Mar 2021
Start Time 08:50 (GMT +8)
Where
Virtual Conference
The Maternal and Infant Health Congress: Asia is being held virtually. The platform we have chosen is designed to facilitate collaboration between key leaders from academia and industry. You can seamlessly network with them and the other attendees as you explore the latest scientific and business developments in maternal-infant health.
Watch this video to discover more…
There is a growing body of evidence showing that the infant microbiome has a long-term impact on human health. Further research has shown that exchanges of the microbiota between infant and mother are essential to the establishment of the infant microbiome. What then are the effects on the maternal and infant health of nutritional intake during pregnancy?
The Maternal and Infant Health Congress Asia explores how research is advancing our understanding of this exciting area and developing new ways to improve the health of future generations. Through a series of case studies, we explore how pregnancy, modes of birth, breastfeeding, diet and antibiotic usage, can influence the microbiome and disease outcomes such as obesity, asthma, allergies and neurodevelopment disorders to name a few.
This meeting is a spin-off from our Microbiome Asia series and is running concurrently with the 2nd Asia Skin Microbiome Congress.
Make a note of the meeting dates in your calendar – 3rd March 2021.